Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	101,612	104,849	74,127	55,834	61,457	56,303
Market Cap Growth	33.75%	41.44%	32.76%	-9.15%	9.15%	32.95%
Enterprise Value	105,790	91,965	65,181	49,750	55,853	52,956
Last Close Price	447.50	406.89	288.78	219.60	236.34	218.95
PE Ratio	-	28.97	22.31	23.84	22.66	47.84
Forward PE	21.76	24.44	18.83	16.42	21.77	37.33
PS Ratio	10.87	10.62	8.30	7.37	9.90	13.53
PB Ratio	7.38	5.96	5.33	5.53	7.07	9.25
P/TBV Ratio	8.75	6.70	6.07	6.42	8.44	12.02
P/FCF Ratio	-	31.42	18.88	23.18	20.53	37.69
P/OCF Ratio	-	29.64	17.95	21.12	18.89	35.88
PEG Ratio	1.32	1.92	0.58	1.62	1.05	1.51
EV/Sales Ratio	9.96	9.32	7.30	6.57	9.00	12.72
EV/EBITDA Ratio	23.79	20.54	14.40	12.38	17.66	40.46
EV/EBIT Ratio	24.96	21.35	14.89	12.78	18.29	44.06
EV/FCF Ratio	-	27.56	16.61	20.66	18.66	35.45
Debt / Equity Ratio	0.11	0.05	0.06	0.10	0.11	0.11
Debt / EBITDA Ratio	0.39	0.18	0.20	0.24	0.30	0.51
Debt / FCF Ratio	-	0.24	0.23	0.40	0.31	0.45
Asset Turnover	0.48	0.48	0.57	0.60	0.62	0.57
Inventory Turnover	5.58	7.38	8.87	8.97	10.62	15.78
Quick Ratio	2.08	3.60	4.46	4.04	4.02	3.33
Current Ratio	2.47	3.99	4.83	4.46	4.33	3.61
Return on Equity (ROE)	-2.99%	22.99%	27.67%	24.93%	36.71%	22.37%
Return on Assets (ROA)	12.05%	13.17%	17.33%	19.32%	19.02%	10.32%
Return on Capital (ROIC)	15.29%	16.22%	21.15%	23.51%	23.30%	12.75%
Earnings Yield	-0.42%	3.45%	4.48%	4.19%	4.41%	2.09%
FCF Yield	-0.96%	3.18%	5.30%	4.31%	4.87%	2.65%
Buyback Yield / Dilution	0.91%	-0.54%	0.31%	1.33%	-1.04%	-0.58%
Total Shareholder Return	0.91%	-0.54%	0.31%	1.33%	-1.04%	-0.58%

Source: S&P Capital IQ. Standard template. Financial Sources.